Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate vs Curcumin in Type 2 Diabetes
NCT04528212Phase 4Completed
- Sponsor
- Rehab Werida
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenofibrate, curcumin in type 2 diabetes mellitus (T2DM), sponsored by Rehab Werida. Started Nov 2020; status: completed.
02
Drugs
fenofibratecurcumin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04528212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528212.